Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

PHASE2CompletedINTERVENTIONAL

Enrollment

232

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Breast CancerNeutropenia

Interventions

DRUG

F-627

subcutaneous injection given 1 per chemotherapy.

DRUG

Neulasta® (pegfilgrastim)

Single dose injection given once per chemotherapy cycle.

Trial Locations (1)

Community Hospital of Anderson, Anderson